Dr. Bruce Pollock
Dr. Bruce Pollock

Available Translations

Dr. Bruce Pollock









Research Focus

Dr. Pollock's long-term goal is to teach and conduct research in geriatric clinical psychopharmacology. His work includes: 1) clinical studies examining neurochemical selectivity, pharmacokinetics, and neurophysiological-therapeutic effects of conventional or newly derived/modified agents for the treatment of depression and the behavioral disturbances of dementia, and 2) examination of age-related changes in drug metabolism and pharmacodynamics toward optimizing treatment with antidepressants and antipsychotics. Particular attention is given to effects on cognition, balance, psychomotor and cardiovascular function. The overarching objective of this research is improved therapeutics.

Publications

481 publications in total

Education

  • 1987: PhD, Pharmacology, School of Medicine University of Pittsburgh PA, USA
  • 1979: M.D., Medicine, Faculty of Medicine University of Toronto Ontario, Canada
  • 1975: BSc, Biological Sciences, University of Toronto Ontario, Canada

Professional Affiliations

  • 1981–Present: Canadian Psychiatric Association
  • 1984–Present: American Medical Association
  • 1984–Present: American Psychiatric Association
  • 1986–Present: American College of Clinical Pharmacology
  • 1987–Present: American Federation for Clinical Research
  • 1988–Present: American Geriatrics Society
  • 1988–Present: American Society for Clinical Pharmacology and Therapeutics
  • 1989–Present: Society of Biological Psychiatry
  • 1991–Present: Canadian Academy of Geriatric Psychiatry
  • 1992–Present: Pennsylvania/West Virginia Geriatrics Society
  • 1992–Present: American Association for Geriatric Psychiatry
  • 1992–Present: International Assoc of Therapeutic Drug Monitoring and Clinical Toxicology
  • 2001–Present: American College of Neuropsychopharmacology
  • 2001–Present: International College of Geriatric Psychoneuropharmacology

Reviewership

Consulting

  • 1988–1989: Editorial Consultant, Williams & Wilkins Publishers, Baltimore, MD
  • 1989: The Ontario Mental Health Foundation, Toronto
  • 1993–Present: Editorial Consultant to Drug Evaluation Program of Adis International for Drugs and Aging, CNS Drugs and Clinical Drug Investigation
  • 1995–1996: Alzheimer Disease Study Units Steering Committee
  • 1995–2000: Reviewer for Am Assoc Geriatric Psychiatry, Young Investigator Awards
  • 1996–Present: Reviewer for Am Assoc Geriatric Psychiatry, Annual Meeting Submissions
  • 1995–Present: Editorial Consultant, Women’s Health Advocate, San Diego, CA
  • 1995–Present: SmithKline Beecham National Advisory Panel
  • 1997–Present: Forest Laboratories National Advisory Panel
  • 1997–Present: National Institute of Mental Health, Mental Disorders of the Aging Research Branch, Ad hoc reviewer on MERIT application.
  • 1997–1998: Advisor to American Psychiatric Association Handbook of Psychiatric Measures
  • 1997–1998: Member, Committee on Pharmacokinetics and Drug Interactions in the Elderly. Divisions of Neuroscience and Behavioral Health and Health Policy, Institute of Medicine, National Academy of Sciences.
  • 1998–Present: Editorial Consultant to Patient Care, Med Economics Press, Montvale, NJ
  • 1998–Present: American Federation for Aging Res, Merck/AFAR Research Scholarship Program
  • 1998–Present: Medical Research Council of Canada, External Referee
  • 1998–Present: Editorial Consultant, American Geriatrics Society
  • 1999–Present: Pennsylvania Drug Use Review Board
  • 1999–Present: Advisory Committee, Sierra-Pacific MIRECC, Department of Veterans Affairs
  • 1999–Present: Scientific Advisory Board, Janus Pharmaceuticals
  • 1999–Present: Editorial Consultant, Clinical Psychiatry News
  • 1999–2010: Advisory Board, Pharmacia & Upjohn
  • 2000–Present: Geriatric Advisory Board, Organon
  • 2000–Present: National Institute of Mental Health, Special Emphasis Panel ZMH1 BRB-P 03 A
  • 2000–Present: U.S. Pharmacopeia Gerontology Expert Committee
  • 2004–Present: Food and Drug Administration, Psychopharmacologic Drug Advisory Committee
  • 2005–Present: Wellcome Trust (UK)
  • 2005–Present: Extramural Advisory Board of the National Institute on Alcohol Abuse and Alcoholism

Committee

  • 1990–1991: Acting Medical Director, Diagnostic and Evaluation Center; School of Medicine, University of Pittsburgh
  • 1989–1992: Member, Institutional Review Board - Biomedical; School of Medicine, University of Pittsburgh
  • 1988–1992: Member: Pharmacy and Therapeutics Committee, Formulary Subcommittee, Patient Medication Information Task Force; School of Medicine, University of Pittsburgh
  • 1985–Present: Reviewer for Research Committee; School of Medicine, University of Pittsburgh
  • 1982–1983: Member, Utilization, Emergency, and Resident Education Committees; Clarke Institute of Psychiatry, University of Toronto
  • 1982–1983: Member, Medical Advisory Committee; Clarke Institute of Psychiatry, University of Toronto
  • 1982–1983: Executive of the Research Committee; Department of Psychiatry, University of Toronto
  • 1981–1982: Member, Academic Lectures Subcommittee; Department of Psychiatry, University of Toronto
  • 1980–1983: Psychiatric Residents Association of Toronto Council; Department of Psychiatry, University of Toronto
  • 1980–1983: Member, Research Committee; Department of Psychiatry, University of Toronto
  • 1980–1983: Member, Postgraduate Education Committee; Department of Psychiatry, University of Toronto
  • 1980–1981: Organizing Committee, International Conference on the Future of Undergraduate Psychiatric Education; Faculty of Medicine, University of Toronto
  • 1979–1980: Decanal Search Committee, Faculty of Medicine; Faculty of Medicine, University of Toronto
  • 1978–1979: Chairman, Laurie Chute Award Committee; Faculty of Medicine, University of Toronto
  • 1977–1979: Representative, University of Toronto Medical Society; Faculty of Medicine, University of Toronto
  • 1977–1979: Council of the Faculty of Medicine, Science Policy Committee; Faculty of Medicine, University of Toronto
  • 1991–1992: Member, Research Pharmacy Oversight Committee; School of Medicine, University of Pittsburgh
  • 1992–1994: Alternate Member, Biomedical IRB; School of Medicine, University of Pittsburgh
  • 1991–1993: Interviewer of Medical School Applicants; School of Medicine, University of Pittsburgh
  • 1991–1993: Membership Committee, Pennsylvania/West Virginia Geriatrics Society
  • 1991–1995: Member, Highland Drive VA Medical Center, Research and Development Committee; School of Medicine, University of Pittsburgh
  • 1992–Present: Member, WPIC Research Committee; School of Medicine, University of Pittsburgh
  • 1992–Present: Mentor, Program for Minority Research Training in Psychiatry
  • 1992–1993: Allegheny County Medical Society, Bioethics Advisory Committee
  • 1992–1995: Invited by American College of Neuropsychopharmacology to assist in prep. of the 1st written examination for the Department of Defense Psychotherapeutic Drug Training Program for Clinical Psychology
  • 1993–Present: Member, WPIC Clinical Trials Subcommittee; School of Medicine, University of Pittsburgh
  • 1993–Present: Member, Residency Recruitment Committee; School of Medicine, University of Pittsburgh
  • 1993–1995: Member, Dept of Psychiatry, Research Strategic Planning Committee, Chairman, Psychopharmacology Research Subcommittee; School of Medicine, University of Pittsburgh
  • 1993–1996: Elected departmental representative to the University Planning and Budgeting Committee; School of Medicine, University of Pittsburgh
  • 1994–Present: Academic Promotions Committee, Chairman, Subcommittee on Non-Tenure Stream Contract Renewals (1995-96); School of Medicine, University of Pittsburgh
  • 1994–1995: Member, Steering Committee for UPMC Pharmacy; University of Pittsburgh Medical Center
  • 1995: Member, Pharmacy Director Search Committee; University of Pittsburgh Medical Center
  • 1995: Member, Search Committee for Puig-Antich Chair in Child Psychiatry; School of Medicine, University of Pittsburgh
  • 1995–Present: Member, Pharmacy and Therapeutics Committee; School of Medicine, University of Pittsburgh
  • 1995–Present: Member, Executive Committee of the Mental Health Clinical Research Center for the Study of Late-Life Mood Disorders; School of Medicine, University of Pittsburgh
  • 1995–1997: Member, Competitive Medical Research Fund Review Committee; University of Pittsburgh Medical Center
  • 1996–Present: Research Committee, American Association for Geriatric Psychiatry
  • 1996–1997: Member, Grants Process/IRB Advisory Group; School of Medicine, University of Pittsburgh
  • 1996–1998: Member, General Clinical Research Center Advisory Committee; University of Pittsburgh Medical Center
  • 1997: Ad Hoc Sub-Committee on Treatment Algorithms, for Clinical Pathways Project; School of Medicine, University of Pittsburgh
  • 1997–Present: Chair, Departmental Quality Assurance Committee for Human Research Subjects; School of Medicine, University of Pittsburgh
  • 1997–Present: Member, Departmental Committee on Pharmaceutical Research; School of Medicine, University of Pittsburgh
  • 1997–Present: New Technology and Expert Consultant Panel, Community Care Behavioral Health
  • 1997–Present: Planning Committee for Geriatric Psychiatric Alliance Depression/Comorbidity Educational Program
  • 1997–1998: National Academy of Sciences, Institute of Medicine, Committee on Pharmacokinetics and Drug Interactions in the Elderly
  • 1997–1999: Program Committee for Annual Meetings, American Association for Geriatric Psychiatry
  • 1998–Present: Chair, Program Committee, 1999 Annual Meeting, American Association for Geriatric Psychiatry
  • 1999–Present: Member, Clinical Neuroscience Research Center Scientific Advisory Committee; School of Medicine, University of Pittsburgh
  • 1999–Present: Member, UPMC Health Plan Pharmacy and Therapeutics Committee; University of Pittsburgh Medical Center
  • 1999–Present: Member, Executive Committee, UPMC Stroke Institute; University of Pittsburgh Medical Center
  • 1999–Present: Member, Selection Committee for Editor-in-Chief of the American Journal of Geriatric Psychiatry
  • 2000–Present: Member, Department of Psychiatry Academic Council; School of Medicine, University of Pittsburgh
  • 2000–Present: Member, UPMC/BEST Psychotropics Subcommittee; University of Pittsburgh Medical Center
  • 2000–Present: Member, Functional Imaging Research Program, Scientific Advisory Committee; University of Pittsburgh Medical Center
  • 2000–Present: Member, University of Pittsburgh Institutional Data and Safety Monitoring Board (IDSMB); University of Pittsburgh Medical Center
  • 2000–Present: Alzheimer’s Association, committee for the J. L. Foster Lecture Series
  • 2000–2002: Alzheimer's Association, Work Group on interventions for Alzheimer’s Disease
  • 2000–2003: Elected to the Board of the American Association for Geriatric Psychiatry
  • 2000–2005: U.S. Pharmacopeia Gerontology Expert Committee
  • 2001–Present: Academic Promotions Committee; School of Medicine, University of Pittsburgh
  • 2001–Present: WPIC Research Day Committee; School of Medicine, University of Pittsburgh
  • 2001–Present: International College of Geriatric Psychoneuropharmacology, Ethics Committee
  • 2001–2002: Mayview State Hospital Collaborative Committee
  • 2002: Center for Healthy Aging, Medical Advisory Medical Advisory Board
  • 2002–Present: International College of Geriatric Psychoneuropharmacology, Co-Chair, Awards Committee
  • 2002–2005: American Federation for Aging Research, Merck/AFAR Junior Investigator in Geriatric Clinical Pharmacology Review Committee
  • 2004–Present: Member, Scientific Advisory Board, Center for Integrative Medicine; University of Pittsburgh Medical Center
  • 2004–2005: Secretary/Treasurer-elect, American Association for Geriatric Psychiatry
  • 2004–2005: Planning Committee, 8th International Meeting, Clinical Pharmacology in Psychiatry
  • 2005: Departmental Senior Advisory Committee; Department of Psychiatry, University of Toronto
  • 2005: Departmental Programme Heads Committee; Department of Psychiatry, University of Toronto
  • 2005–Present: Clinical Research Infrastructure Working Group; Faculty of Medicine, University of Toronto
  • 2005–2006: Secretary/Treasurer, American Association for Geriatric Psychiatry
  • 2006: Departmental Search Committee for Head of Neuroscience Program; Department of Psychiatry, University of Toronto
  • 2006: Departmental Centennial Event Steering Committee; Department of Psychiatry, University of Toronto
  • 2006–Present: Departmental Promotions Committee; Department of Psychiatry, University of Toronto

Editorial Board

  • 1994: Treating the Blues (Newsletter for Primary Care Physicians), Guest Editor
  • 1996: Journal of Geriatric Psychiatry and Neurology
  • 1998: The Consultant Pharmacist
  • 1998–2000: Issues in Depression: Index & Reviews, (Lippincott Williams& Wilkins)
  • 2001: Geriatrics At Your Fingertips, 4-8th editions (Am Geriatrics Society)
  • 2001–2004: The American Journal of Geriatric Psychiatry
  • 2003: The American Journal of Geriatric Pharmacotherapy
  • 2003: Mental Fitness
  • 2005: Aging Health
  • 2005: Canadian Journal of Psychiatry
  • 2005: Current Psychiatry
  • 1984: American Journal of Psychiatry, Washington, DC
  • 1988: Archives of General Psychiatry, Chicago, IL
  • 1989: Journal of Clinical Psychiatry, Memphis, TN
  • 1989: Journal of Neuropsychiatry and Clinical Neurosciences, Washington, DC
  • 1989: Journal of Affective Disorders, Iowa City, IA
  • 1990: Review Board, Hospital Formulary, Cleveland, OH
  • 1991: Journal of Clinical Psychopharmacology, Boston, MA
  • 1992: International Journal of Geriatric Psychiatry, New York, NY
  • 1994: CNS Drugs, Auckland, New Zealand
  • 1994: American Journal of Geriatric Psychiatry, Washington, DC
  • 1994: Journal of Psychiatric Research, Elsevier Science, Ireland
  • 1995: Annals of Neurology, San Francisco
  • 1997: Clinical Drug Investigation, Auckland, NZ
  • 1998: Psychopharmacology, Berlin,Heidelberg, Germany
  • 1998: Canadian Journal of Clinical Pharmacology
  • 1998: Journal of Psychiatry & Neuroscience,Ottawa, Canada
  • 2000: Depression and Anxiety, New York, NY
  • 2000: Pharmacotherapy, Carlisle

Distinctions and Awards

  • 2006: The Best Doctors in America, 3rd – 10th Editions
  • 2005: Guide to America’s Top Psychiatrists, Consumer Research Council of America
  • 2005: Who’s Who in America, 53rd - 60th, Editions
  • 2004: Who’s Who in Medicine and Health Care, 1st – 6th Editions
  • 2003: Distinguished Fellow, American Psychiatric Association
  • 2003: Distinguished Scientist Award, American Association for Geriatric Psychiatry
  • 2002: Independent Scientist Award, National Institute of Mental Health
  • 1997: Academic Award in Geriatric Mental Health, National Institute of Mental Health
  • 1991: Merck Fellow in Geriatric Clinical Pharmacology, American Federation for Aging Research
  • 1986: Centennial Fellow, Medical Research Council of Canada
  • 1983: Laughlin Fellow, American College of Psychiatrists
  • 1979: Pfizer Pharmaceutics Research Award for Best Resident Paper, Department of Psychiatry , University of Toronto
  • 1978: Medical Alumni-Medical Society Prose Contest Prize, Univ of Toronto
  • 1976: Summer Scholarship, Department of Surgery, University of Toronto
  • 1975: Dr. H.C. Parson's Scholarship, Trinity College, University of Toronto
  • 1972: General Proficiency Prize and Bowes Prize in English
  • 1969: Ontario Scholar, Province of Ontario

Research Projects

External

  • 2005–2010: Efficacy of Adjunct Sleep Interventions for PTSD
    Collaborators: A. Germain; B.G. Pollock (Consultant; Laboratory Support)

    Sponsors: Department of Defense, 24,801 (USD)

  • 2005–2010: Advanced Center for Interventions and Services Research for Late-Life Mood Disorders
    Collaborators: C. Reynolds, B.G. Pollock

    Sponsors: National Institute of Mental Health, 2,962,260 (USD)

  • 2005–2009: Maintenance Therapies in Late-Life Depression –III
    Collaborators: B.G. Pollock

    Sponsors: National Institute of Mental Health, 1,988,394 (USD)

  • 2004–2009: Neuroscience-Guided Remediation of Cognitive Deficits in Schizophrenia
    Collaborators: S. Vinogradov; B.G. Pollock

    Sponsors: National Institute of Mental Health, 36,000 (USD)

  • 2003–2008: Advanced Research Institute in Geriatric Psychiatry
    Collaborators: M. Bruce; B.G. Pollock (Core Faculty/Mentor)

    Sponsors: National Institute of Mental Health

  • 2003–2008: Predicting Alcoholic Treatment Response to a SSRI
    Collaborators: R. Anthenelli; B.G. Pollock

    Sponsors: National Institute on Alcohol Abuse and Alcoholism, 55,140 (USD)

  • 2003–2008: Serotonin Modulation in Geriatric Depression
    Collaborators: G. Smith; B.G. Pollock

    Sponsors: National Institute of Mental Health, 152,560 (USD)

  • 2003–2008: Depression: The Search for Treatment-Relevant Phenotypes
    Collaborators: E. Frank; B.G. Pollock

    Sponsors: National Institute of Mental Health, 686,895 (USD)

  • 2004–2007: Development of an Anticholinergic Burden Risk Assessment Tool
    Collaborators: B.G. Pollock (Co-Principal Investigator)

    Sponsors: Janssen Pharmaceutica Inc., 204,700 (USD)

  • 2003–2007: Commonwealth Center of Excellence for Bipolar Disorder
    Collaborators: D.J. Kupfer; B.G. Pollock

    Sponsors: Commonwealth of Pennsylvania

  • 2002–2007: Clinical Research Training in Late-Life Mood Disorder
    Collaborators: C.F. Reynolds; B.G. Pollock

    Sponsors: National Institute of Mental Health

  • 2002–2007: Medication Adherence in Older Psychotic People
    Collaborators: J. Lacro; B.G. Pollock

    Sponsors: National Institute of Mental Health, 39,000 (USD)

  • 2002–2007: Geropsychopharmacology: Enhancing Benefit, Reducing Risk
    Collaborators: B.G. Pollock

    Sponsors: National Institute of Mental Health, 544,390 (USD)

  • 2002–2006: Anticholinergic Drugs, Cognitive Deficits & Normal Aging
    Collaborators: R.D. Nebes; B.G. Pollock

    Sponsors: National Institute on Aging, 700,000 (USD)

  • 2000–2006: Continuation Pharmacotherapy for Agitation of Dementia
    Collaborators: B.G. Pollock

    Sponsors: National Institute of Mental Health, 1,163,305 (USD)

  • 2001–2005: Atypical Antipsychotics: Determinants of Concentration
    Collaborators: B.G. Pollock

    Sponsors: National Institute of Mental Health, 800,000 (USD)

  • 2000–2005: IRC for the Study of Late Life Mood Disorders
    Collaborators: B.G. Pollock; C.F. Reynolds

    Sponsors: National Institute of Mental Health, 5,432,131 (USD)

  • 2000–2005: Treatment of Resistant Depression in Adolescents
    Collaborators: D. Brent; B.G. Pollock (Laboratory Director)

    Sponsors: National Institute of Mental Health, 15,974 (USD)

    Lab component
  • 2000–2005: MHIRC for Mood and Anxiety Disorders-Treatment Indications and Optimization Core
    Collaborators: David J. Kupfer; B.G. Pollock

    Sponsors: National Institute of Mental Health, 1,331,245 (USD)

  • 2001–2004: St. John’s Wort and CYP3A metabolism in men & women
    Collaborators: R. Frye; B.G. Pollock

    Sponsors: National Institute of Mental Health, 700,000 (USD )

Curriculum Vitae

Download Curriculum Vitae here

Contact

The Rotman Research Institute
Baycrest
3560 Bathurst Street, 838
Toronto, Ontario,
Canada M6A 2E1 Phone: (416) 785-2500 x2908 Email: bpollock@rotman-baycrest.on.ca Fax: (416) 785-2862